FI110511B - Förfarande för framställning av nya 3-cykloalkyl-propanamider, deras tautomerer och deras salter - Google Patents
Förfarande för framställning av nya 3-cykloalkyl-propanamider, deras tautomerer och deras salter Download PDFInfo
- Publication number
- FI110511B FI110511B FI915091A FI915091A FI110511B FI 110511 B FI110511 B FI 110511B FI 915091 A FI915091 A FI 915091A FI 915091 A FI915091 A FI 915091A FI 110511 B FI110511 B FI 110511B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- cyclopropyl
- hal
- compound
- oxopropionitrile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (5)
1. Förfarande för framställning av nya tera-peutiskt användbara 3-cykloalkylpropanamider med den all-5 manna formeln I: R4\ 3 O O Ra „ R2 CN 6. z där - Ri stär för en cykloalkylgrupp med 3-6 kolatomer,
15. R2 stär för en väteatom eller en alkylradikal med 1-3 kolatomer, - R3, R4, R5, Rö and R7, vilka är lika eller olika, star för en väteatom, en halogenatom, en rakkedjad eller förgrenad alkylradikal med 1-6 kolatomer, en rakkedjad eller för- , 20 grenad alkoxiradikal med 1-6 kolatomer, en alkyltioradi- ;· kai med 1-6 kolatomer, grupper - (CH2)m-CF3, -O-(CH2) m-CF3, -S-(CH2) m-CF3, där m star för ett heltal 0 -; 3, en grupp -CF2-Hal, -OCF2-Hal, 25 ,F ^F ^F - (CF2)n-C;—- Hall, -0(CF2)n-C~-Hal1, -S(CF2)n-C--Hali eller '"S'vHal2 ^Halz V>vHal2 0(CF2)n-CF-Hal3-CF3 30 där n stär för ett heltal 1-3, Hali och Hal2, vilka är *! . lika eller olika, och Hai och Hal3 stär för en halogenatom, V eller R3, R4, Rs, R6 och R7, vilka är lika eller olika, stär för en nitrogrupp, en azidogrupp, en nitrilgrupp, en 35 -CO-R'-grupp, där R' stär för en hydroxigrupp eller en alkyl- eller alkoxiradikal med 1-3 kolatomer, eller R4 110511 37 och R5 tillsammans bildar en -0-CH2~0-grupp, tautomera former därav samt additionssalter därav med oorganiska eller organiska baser, kännetecknat av att en förening med formeln (II): 5 R5—/ V—™ (ID / \ R,
10 R ' 2 R6 *7 där R2, R3, R4, R5, Rg och R7 betecknar samma som ovan, om- sätts med en syra som har formeln (III) eller ett funk- tionellt derivat därav: 15 I-CN (III) HO O , ,,· 20 varvid erhälls en förening med formeln (IV): ’··; 4\_/3 -cn (iv)
25 RS \__ R6 Xr7 R' där R2, R3, R4/ R5, R6 och R7 betecknar samma som ovan, va- 30 refter den sistnämnda föreningen omsätts successivt med natriumhydrid, och om det behövs, i närvaro av en katalyt, ( . säsom imidazol, sedan med en förening som har formeln (V): Hal-CO-Ri (V) 38 110511 där Hal star för en halogenatom ooh Ri betecknar samma som ovan, varvid erhälls motsvarande förening med formeln (I), som isoleras och eventuellt omvandlas tili ett sait.
2. Förfarande enligt patentkrav 1, kanne-5 tecknat av att: - reaktion av en förening, som har formeln (II) , med en syra, som har formeln (III), eller med ett funktionellt de-rivat därav utförs i närvaro av diisopropylkarbodiimid eller dicyklohexylkarbodiimid i ett vattenfritt organiskt 10 lösningsmedel, sasom tetrahydrofuran eller diklormetan, - det funktionella derivatet av en syra med formeln (III) kan vara tili exempel cyanacetylklorid, som framställts in situ genom att omsätta cyanättiksyra med fosforpentaklorid, - reaktion av en förening, som har formeln (IV), med nat-15 riumhydrid utförs i ett vattenfritt organiskt lösningsmedel, säsom tetrahydrofuran.
3. Förfarande enligt patentkrav 1 eller 2, k ä n-netecknat av att som utgangsämne används en förening med formeln (II), där R3, R4, Rs, R6 och R7, vilka är 20 lika eller olika, star för en väteatom, en fluor-, klor-, brom- eller jodatom, en metyl-, etyl-, terbutyl-, metoxi-, metyltio-, trifluormetyl-, trifluormetoxi-, trifluorme-tyltio-, pentafluoretyl-, bromdifluormetoxi-, acetyl-, hyd-roxikarbonyl-, metoxikarbonyl-, nitro-, azido- eller ni-25 trilradikal eller R4 och Rs tillsammans bildar en 0-CH2-0- ’ ' grupp, och R2 stär för en väteatom eller en metylradikal.
4. Förfarande enligt nägot av patentkrav 1 - 3, V kännetecknat av att som utgangsämne används en förening med formeln (II) , där R2 stär för en väteatom el-30 ler en metylradikal, R3, R4, R5, R6 och R7, vilka är lika eller olika, stär för en väteatom, en fluor-, klor- eller . jodatom, en metyl-, trifluormetyl- eller nitroradikal, och | , en förening med formeln (V), där R4 stär för en cyklopro- pylgrupp. * t ♦ 110511 39
5. Förfarande enligt nägot av patentkrav 1 - 4, kännetecknat av att föreningarna med formlerna (II) och (V) väljs sä att man framställer nägon av de föl-jande föreningarna med formeln (I): 5 - 1-(4-nitrofenylkarbamyl)-2-cyklopropyl-2-oxopropionitril, - 1-(4-cyanfenylkarbamyl)-2-cyklopropyl-2-oxopropionitril, 1-(4-klor-3-metylfenylkarbamyl)-2-cyklopropyl-2-oxoprop-ionitril, 1-(3-metyl-4-trifluormetylfenylkarbamyl)-2-cyklobutyl-2-10 oxopropionitril, 1-(4-cyan-3-metylfenylkarbamyl)-2-cyklopropyl-2-oxopro-pionitril, - eller ett additionssalt därav med oorganiska eller or-ganiska baser. » I * • · • · 1 ( » »
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9023535 | 1990-10-30 | ||
GB909023535A GB9023535D0 (en) | 1990-10-30 | 1990-10-30 | Chemical compounds |
GB919105516A GB9105516D0 (en) | 1990-10-30 | 1991-03-15 | Chemical compounds |
GB9105516 | 1991-03-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI915091A0 FI915091A0 (fi) | 1991-10-29 |
FI915091A FI915091A (fi) | 1992-05-01 |
FI110511B true FI110511B (sv) | 2003-02-14 |
Family
ID=26297867
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI915091A FI110511B (sv) | 1990-10-30 | 1991-10-29 | Förfarande för framställning av nya 3-cykloalkyl-propanamider, deras tautomerer och deras salter |
FI20021681A FI119986B (sv) | 1990-10-30 | 2002-09-20 | Nya mellanprodukter |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20021681A FI119986B (sv) | 1990-10-30 | 2002-09-20 | Nya mellanprodukter |
Country Status (25)
Country | Link |
---|---|
US (2) | US5240960B1 (sv) |
EP (1) | EP0484223B1 (sv) |
JP (1) | JP2594855B2 (sv) |
CN (1) | CN1030075C (sv) |
AT (1) | ATE119518T1 (sv) |
AU (1) | AU641290B2 (sv) |
BG (1) | BG61924B2 (sv) |
BR (1) | BR9104711A (sv) |
CA (1) | CA2054473C (sv) |
CZ (1) | CZ282036B6 (sv) |
DE (1) | DE69107959T2 (sv) |
DK (1) | DK0484223T3 (sv) |
ES (1) | ES2069854T3 (sv) |
FI (2) | FI110511B (sv) |
GE (1) | GEP19981035B (sv) |
GR (1) | GR3015335T3 (sv) |
HR (1) | HRP920979B1 (sv) |
HU (2) | HU215051B (sv) |
IE (1) | IE69330B1 (sv) |
IL (1) | IL99811A (sv) |
NO (1) | NO175898C (sv) |
NZ (1) | NZ240403A (sv) |
PT (1) | PT99381B (sv) |
SI (1) | SI9111731B (sv) |
SK (1) | SK281720B6 (sv) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99811A (en) * | 1990-10-30 | 1996-03-31 | Roussel Uclaf | 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them |
IL102790A (en) * | 1991-09-17 | 1996-01-31 | Roussel Uclaf | History of 3-cycloalkyl-prop-2-anamide |
ES2079765T3 (es) * | 1991-10-23 | 1996-01-16 | Hoechst Ag | Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora. |
GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
GB9300083D0 (en) * | 1993-01-05 | 1993-03-03 | Roussel Lab Ltd | Chemical compounds |
TW314467B (sv) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
GB9313365D0 (en) * | 1993-06-29 | 1993-08-11 | Roussel Lab Ltd | Chemical compounds |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
FR2727628B1 (fr) * | 1994-12-02 | 1997-01-10 | Roussel Uclaf | Application des derives de 3-cycloalkyl-propanamide a titre de medicaments analgesiques |
GB9520092D0 (en) * | 1995-10-02 | 1995-12-06 | Hoechst Roussel Ltd | Chemical compounds |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19547648A1 (de) | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US6355678B1 (en) | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
AU731777B2 (en) | 1998-11-30 | 2001-04-05 | Nihon Nohyaku Co., Ltd. | Aniline derivative and process for producing the same |
US6566395B1 (en) | 1999-05-25 | 2003-05-20 | Biomedicines, Inc. | Methods of treating proliferative disorders |
JP2016537360A (ja) | 2013-11-22 | 2016-12-01 | ジェンザイム・コーポレーション | 神経変性疾患を治療するための新規な方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR831461A (fr) * | 1937-01-09 | 1938-09-05 | Ste Ind Chim Bale | Nouveaux produits de condensation |
US3116312A (en) * | 1960-03-31 | 1963-12-31 | American Cyanamid Co | Substituted-2-cyanoacetanilides |
NL6911567A (sv) * | 1968-08-08 | 1970-02-10 | ||
DE2307156A1 (de) * | 1973-02-14 | 1974-08-22 | Henkel & Cie Gmbh | N,n-disubstituierte alpha-cyanacrylsaeureamide und deren herstellung |
DE2555789A1 (de) * | 1975-12-11 | 1977-07-07 | Hoechst Ag | Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
US4393217A (en) * | 1981-01-12 | 1983-07-12 | American Cyanamid Company | Substituted phenyl-5-aminopyrazoles |
US4946867A (en) * | 1987-09-07 | 1990-08-07 | Sumitomo Chemical Company, Limited | Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient |
US4888357A (en) * | 1988-01-26 | 1989-12-19 | Bristol-Myers Company | Antiarthritic β-cycloalkyl-β-oxopropionitriles |
US5034410A (en) * | 1989-10-11 | 1991-07-23 | Syntex (U.S.A.) Inc. | Anthelmintically active benzenepropanamide derivatives |
IL99811A (en) * | 1990-10-30 | 1996-03-31 | Roussel Uclaf | 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them |
-
1991
- 1991-10-21 IL IL9981191A patent/IL99811A/en not_active IP Right Cessation
- 1991-10-29 DE DE69107959T patent/DE69107959T2/de not_active Expired - Lifetime
- 1991-10-29 CZ CS913273A patent/CZ282036B6/cs not_active IP Right Cessation
- 1991-10-29 ES ES91402890T patent/ES2069854T3/es not_active Expired - Lifetime
- 1991-10-29 IE IE376891A patent/IE69330B1/en not_active IP Right Cessation
- 1991-10-29 DK DK91402890.7T patent/DK0484223T3/da active
- 1991-10-29 NO NO914232A patent/NO175898C/no not_active IP Right Cessation
- 1991-10-29 JP JP3308260A patent/JP2594855B2/ja not_active Expired - Lifetime
- 1991-10-29 HU HU913394A patent/HU215051B/hu unknown
- 1991-10-29 SK SK3273-91A patent/SK281720B6/sk not_active IP Right Cessation
- 1991-10-29 CA CA002054473A patent/CA2054473C/fr not_active Expired - Lifetime
- 1991-10-29 EP EP91402890A patent/EP0484223B1/fr not_active Expired - Lifetime
- 1991-10-29 AT AT91402890T patent/ATE119518T1/de not_active IP Right Cessation
- 1991-10-29 FI FI915091A patent/FI110511B/sv not_active IP Right Cessation
- 1991-10-30 SI SI9111731A patent/SI9111731B/sl unknown
- 1991-10-30 NZ NZ240403A patent/NZ240403A/en not_active IP Right Cessation
- 1991-10-30 US US07785087 patent/US5240960B1/en not_active Expired - Lifetime
- 1991-10-30 PT PT99381A patent/PT99381B/pt not_active IP Right Cessation
- 1991-10-30 BR BR919104711A patent/BR9104711A/pt not_active Application Discontinuation
- 1991-10-30 CN CN91111132A patent/CN1030075C/zh not_active Expired - Lifetime
- 1991-10-30 AU AU86869/91A patent/AU641290B2/en not_active Expired
-
1992
- 1992-10-02 HR HR920979A patent/HRP920979B1/xx not_active IP Right Cessation
-
1993
- 1993-04-22 US US08/051,178 patent/US5384423A/en not_active Expired - Lifetime
- 1993-07-31 GE GEAP19931341A patent/GEP19981035B/en unknown
-
1994
- 1994-02-23 BG BG98526A patent/BG61924B2/bg unknown
-
1995
- 1995-03-09 GR GR940402650T patent/GR3015335T3/el unknown
- 1995-06-30 HU HU95P/P00667P patent/HU211614A9/hu unknown
-
2002
- 2002-09-20 FI FI20021681A patent/FI119986B/sv not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI110511B (sv) | Förfarande för framställning av nya 3-cykloalkyl-propanamider, deras tautomerer och deras salter | |
HU203725B (en) | Process for producing pyridyl-ethyl-amine derivatives and compositions containing them for improving productivity of animals | |
JP3642797B2 (ja) | フェニルカルボキサミドイソオキサゾールの新誘導体及びそれらの塩類、それらの製造法及びこの製造法の新規な中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物 | |
CA2451990C (en) | A new compound for the treatment of impotence | |
JPH07149743A (ja) | イソオキサゾール誘導体 | |
JPH07507062A (ja) | 7−二置換−メチル−4−オキソ−3H,5H−ピロロ[3,2−d]ピリミジンおよび医薬上の用途ならびにそれを含有してなる組成物 | |
CZ283948B6 (cs) | Nové deriváty 2-kyano-3-hydroxy-propenamidy, jejich způsoby přípravy, jejich užití jako léčiva a farmaceutické kompozice tyto látky obsahující | |
SU1251803A3 (ru) | Способ получени производных ацетамида в виде смеси изомеров или отдельных изомеров | |
CN1274691C (zh) | 两种治疗阳痿的新化合物 | |
RU2073667C1 (ru) | 3-циклоалкил-пропанамиды, проявляющие противовоспалительную и иммуноподавляющую активность, способ их получения, цианамид и фармацевтическая композиция | |
WO2022131146A1 (ja) | 含窒素複素環式化合物 | |
RU2072987C1 (ru) | Производные 3-циклоалкилпропен-2-амида или их аддитивные соли с минеральными или органическими основаниями, способ их получения и фармацевтическая композиция, обладающая противовоспалительной активностью | |
KR810000610B1 (ko) | 6-(m-아미노페닐)-2, 3, 5, 6-테트라하이드로 이미다조[2, 1-b] 티아졸 유도체의 제조방법 | |
FI65237B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara o-nitrofenyltionokarbamoylkarbamater | |
ZA200400692B (en) | New compounds for treating impotence. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |